Navigation Links
Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR
Date:7/11/2014

(PRWEB) July 11, 2014

BCC Research (http://www.bccresearch.com) reveals in its new report, DIGITAL POLYMERASE CHAIN REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS, the global market for digital polymerase chain reaction (PCR) technology reached nearly $140 billion in 2013. This is estimated to grow to $490 billion in 2018, registering a five-year compound annual growth rate (CAGR) of 28.6%.

New digital PCR technology has created a number of interesting and exciting possibilities within the broader PCR field. The opportunities presented by this technology offer some fundamental solutions to issues within PCR, allowing various tasks to be performed more easily and enabling new innovations not previously achievable with existing technology. This will lead to the equipment sector’s anticipated rapid growth from $68.2 billion in 2013 to $283.9 billion by 2018, with a five-year CAGR of 33%, making it the fastest growing segment.

“Digital PCR is a rapidly growing technology that is experiencing a fast uptake and broad adoption in laboratories engaged in molecular biology. Clinical laboratories have turned research into billable laboratory tests and are poised for explosive growth in the revenue generated in these fields,” says BCC Research analyst, Todd Graham. “All firms within this field have reported strong product growth, while reports from the scientific community augur well for continued advancement for the next five years.”

DIGITAL POLYMERASE CHAIN REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS gives a detailed analysis on the digital polymerase chain reaction (PCR) industry, including trend forecasts and sales through 2018. The focus of this report is on the equipment used within the digital PCR sector and their distinct reagents. The different technologies used for digital PCR and their associated reagents are analyzed to explore the scope of the marketplace that exists for this technology.

This report identifies the plethora of market opportunities using digital PCR, focusing on where it can establish itself in the broader marketplace, the applications of the technology, and the implications this technology will have on complementary applications.

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming(at)bccresearch(dot)com.

About BCC Research

BCC Research publishes market research reports that make organizations worldwide more profitable with intelligence that drives smart business decisions. These reports cover today's major industrial and technology sectors, including emerging markets. For more than 40 years, we have helped customers identify new market opportunities with accurate and reliable data and insight, including market sizing, forecasting, industry overviews, and identification of significant trends and key competitors. We partner with analysts who are experts in specific areas of industry and technology, providing unbiased measurements and assessments of global markets. Our clients include the top companies in industries around the world as well as universities, business schools, start-ups, consulting firms and investment companies. BCC Research is a unit of Eli Research LLC. Visit our website at http://www.bccresearch.com. Contact us: (+1) 781-489-7301 (U.S. Eastern time), or email information(at)bccresearch(dot)com.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49-2 Walnut Park, Wellesley, MA 02481, Telephone: (+1) 781-489-7301; Email: editor(at)bccresearch(dot)com as the source and publisher. Thank you.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12011625.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2019)... ... ... Alice Branton today released research results from preclinical trials on the beneficial ... prove to be beneficial for treating Hypomagnesemia. , The preclinical trial shows:, ... , Over 142% increase in particle size , Over 3% ...
(Date:6/12/2019)... EGG HARBOR TOWNSHIP, N.J. (PRWEB) , ... June ... ... premier manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, ... partnership agreement with Shanghai Zillion has been signed. The agreement will grant exclusive ...
(Date:6/11/2019)... Calif. (PRWEB) , ... June 10, 2019 , ... ... today announced IOPP will add 80 of its scientific journals to DeepDyve’s rental ... physics-related content to DeepDyve’s continually expanding library of more than 20 million articles, ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... from human mesenchymal stem cells (MSC-EV) are able to incorporate into human CD34+ ... a test on mice, MSC-EVs also increased the cells’ ability to lodge into ...
Breaking Biology Technology:
(Date:8/1/2019)... ... August 01, 2019 , ... John R. Freeman, CPA, has joined BioLabs as ... president of BioLabs, which provides premier co-working spaces for life science startups in the ... to forecast and manage growth,” says Fruehauf. “BioLabs has expanded to 10 locations in ...
(Date:7/26/2019)... (PRWEB) , ... July 26, 2019 , ... ... announce an exclusive interview with Helius Medical Technologies CEO Phil Deschamps to discuss ... , Helius Medical Technologies is a neurotech company in the medical ...
(Date:7/23/2019)... ... July 23, 2019 , ... ... a 100% bioactive glass synthetic biologic strip indicated for spine and orthopedic use. ... to human bone. Bioactive glass has been clinically-proven in orthopedics for over 30 ...
Breaking Biology News(10 mins):